LICENSE AGREEMENT WITH MGI PHARMA, INC./EISAI CORPORATION (Tables)

9 Months Ended

Sep. 30, 2012

LICENSE AGREEMENT WITH MGI PHARMA, INC./EISAI CORPORATION

Schedule of Dacogen sales and related royalty revenues

Details of Dacogen sales and related royalty revenues were as follows (dollars in thousands):

	Three months ended September 30,				Increase (Decrease)						Nine months ended September 30,				Increase (Decrease)
	2012		2011		Dollar			Percent			2012		2011		Dollar		Percent
Net product sales:
North America	$	55,751	$	60,180	$	(4,429	)		(7.4	)%	$	168,837	$	155,255	$	13,582		8.7	%
Rest of the world		15,255		10,689		4,566			42.7			41,749		31,861		9,888		31.0
Total	$	71,006	$	70,869	$	137			0.2	%	$	210,586	$	187,116	$	23,470		12.5	%
Royalty Revenue	$	16,995	$	16,638	$	357			2.1	%	$	52,030	$	45,148	$	6,882		15.2	%